The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic

Healthcare 2018, 6(1), 16; doi:10.3390/healthcare6010016
Marcus Davidsson
Insert HTML here
Healthcare 2018, 6(1), 16; doi:10.3390/healthcare6010016
Marcus Davidsson
Every province in Canada is now endemic for Lyme disease.
Listen to one of the most rational conversations with an MD about Lyme Disease that we have heard in a while. The notion that there has never been a confirmed case from someone in Alberta who has not traveled is a mute point in that few people were truly investigated for Lyme Disease. Current tests will…
May 6th, 2015 Jessica Bell from the Ontario Lyme Alliance and Jeanne Pacey who suffers from Lyme disease, spoke to CityNews’ Francis D’Souza. Watch City News
October 29 2018, Garga K et al There is insufficient evidence to support screening of various tick-borne diseases (TBD) related microbes alongside Borrelia in patients suffering from TBD. To evaluate the involvement of multiple microbial immune responses in patients experiencing TBD we utilized enzyme-linked immunosorbent assay. Four hundred and thirty-two human serum samples organized into…
An apparent rise in ticks crossing Canada’s southern border has the local health unit urging residents to use caution in wooded areas.
Va. now must disclose the flaws in Lyme disease testing Tuesday, February 26, 2013 BY MARKUS SCHMIDT Richmond Times-Dispatch Lyme disease is one of the fastest-growing infectious diseases in the United States, but despite testing, many patients are not aware that they are infected until it is too late. New legislation passed by Virginia’s General…
Comments are closed.
Interesting article on the issue but does he show where he gets the estimated costs from? Specialists use different treatment regimens but one thing seems clear that high dose short treatments favoured by insurance companies don’t work. Treatment success seems to be more dependant on the length of treatment than what is used and if the average case takes 1.5 years to treat then oral therapy would be easier, more practical and less costly. Too bad there aren’t more side by side studies of treatments and outcomes then there is such a great heterogeneity in the patient population. Allowing half the patients to be treated according to the IDSA guidelines and the other half by ILADS trained physicians would certainly show which group has a better success rate.
I agree with Rob. What I have seen over many years is that an oral regimen over time is as effective or more effective than intravenous. Intravenous has it’s place for serious heart and brain infection. Jim